ClinicalTrials.Veeva

Menu

Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy

Utah System of Higher Education (USHE) logo

Utah System of Higher Education (USHE)

Status

Enrolling

Conditions

Preeclampsia
Cardiovascular Diseases
Hypertension, Pregnancy Induced
Patient Engagement
Hypertension Complicating Pregnancy

Treatments

Other: Decision aid

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05826925
00151518
K23HL159316 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

Cardiovascular disease is the leading cause of death among women in the United States, and women with hypertensive disorders of pregnancy have a 2-fold higher risk for cardiovascular disease later in life compared to women with uncomplicated pregnancies. This research investigates a patient-centered intervention during the postpartum period to promote engagement in cardiovascular preventive care.

Full description

Current evidence demonstrates that women with hypertensive disorders of pregnancy have 2-fold higher risk for the later development of cardiovascular disease (CVD) compared to women with healthy pregnancies. CVD prevention is a high priority for women's health, as it is the leading cause of death among women in the United States. In order to improve women's cardiovascular health, interventions for cardiovascular prevention could be initiated shortly after a pregnancy complicated by a hypertensive disorder. However, patient-centered interventions to promote preventive care engagement among postpartum women are lacking. Our objective is to address current gaps in knowledge regarding needs, values, and barriers regarding cardiovascular prevention among postpartum women with hypertensive disorders of pregnancy, and to remedy the lack of available evidence-based interventions for this at-risk population. To this end, we will conduct a pilot study to demonstrate feasibility and preliminary efficacy of a patient decision aid to improve patient knowledge and self-efficacy regarding CVD prevention during the postpartum period

Enrollment

30 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Delivered a pregnancy complicated by a hypertensive disorder of pregnancy at the University of Utah during the current hospital admission
  • Ability to speak and read English or Spanish
  • Written informed consent obtained

Exclusion criteria

  • Cardiovascular disease diagnosis (history of peripheral artery disease, stroke, or myocardial infarction)
  • Impairment of cognitive function or vision that prohibits communication and/or reading the decision aid.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

30 participants in 2 patient groups

Decision aid
Experimental group
Description:
Participants will use the decision aid in the postpartum period
Treatment:
Other: Decision aid
Usual care
No Intervention group
Description:
Participants will receive standard postpartum care

Trial contacts and locations

1

Loading...

Central trial contact

Lauren Theilen, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems